Blair William & Co. IL reduced its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 83.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 46,583 shares of the company's stock after selling 229,248 shares during the quarter. Blair William & Co. IL's holdings in Option Care Health were worth $1,081,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Murphy & Mullick Capital Management Corp bought a new position in Option Care Health during the 4th quarter valued at $26,000. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC lifted its position in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quarry LP grew its stake in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after purchasing an additional 2,628 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after buying an additional 681 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.
Option Care Health Stock Performance
Shares of Option Care Health stock traded down $0.67 during trading on Monday, hitting $32.87. 2,353,635 shares of the stock were exchanged, compared to its average volume of 1,736,934. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The stock's fifty day moving average is $33.00 and its 200 day moving average is $28.50. The stock has a market cap of $5.40 billion, a PE ratio of 27.62, a P/E/G ratio of 2.30 and a beta of 1.07.
Analysts Set New Price Targets
OPCH has been the subject of several research reports. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Barrington Research increased their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and an average price target of $33.00.
Check Out Our Latest Stock Report on OPCH
Insider Buying and Selling at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by company insiders.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
